GAS5 and breast cancer: Using RNA-seq technology, Chen et al. identified GAS5 as one of the most downregulated lncRNAs in BC MCF7 cells resistant to adriamycin (ADR), an anthracycline widely used as a chemotherapeutic drug for BC.